You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 64 No. 5, May 2007 TABLE OF CONTENTS
  Archives
 •  Online Features
 This Article
 •Abstract
 •Full text
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited

Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease
Arch Neurol Jankovic et al. 64 (5): 676.

Notice of Redundant Publication

The following Notice of Redundant Publication for this article has been published: Roger Rosenberg. Notice of Redundant Publication: "Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease" (Arch Neurol. 2007;645[5]:676-682).

See also the accompanying reply letter: Joseph Jankovic, etal. Notice of Redundant Publication: "Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease" (Arch Neurol. 2007;645[5]:676-682)—Reply.




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.